Scinai Immunotherapeutics (SCNI) Current Assets (2017 - 2026)

Scinai Immunotherapeutics has disclosed Current Assets across 10 years of filings, most recently posting $3.5 million for Q2 2026.

• In Q2 2026, Current Assets rose 131.61% year-over-year to $3.5 million; the TTM figure through Jun 2026 stood at $3.5 million (up 131.61% YoY), while the FY2025 annual figure was $2.1 million, down 14.09% from the prior year.
• Current Assets came in at $3.5 million for Q2 2026 at Scinai Immunotherapeutics, down from $3.6 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $14.4 million in Q4 2022 to a low of $1.5 million in Q2 2025.
• Average Current Assets over 5 years is $5.9 million, with a median of $5.3 million recorded in 2024.
• Year-over-year, Current Assets tumbled 75.91% in 2024 and surged 131.61% in 2026.
• Over 5 years, Current Assets stood at $14.4 million in 2022, then plunged by 62.09% to $5.4 million in 2023, then plunged by 56.1% to $2.4 million in 2024, then declined by 14.09% to $2.1 million in 2025, then jumped by 69.81% to $3.5 million in 2026.
• Per Business Quant data, the three most recent Current Assets figures were $3.5 million in Q2 2026, $3.6 million in Q1 2026, and $2.1 million in Q4 2025.